CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Coming to Lab Expectations in 2020

Read More
All Posts

            The start of a new year is always a crazy time. There’s plenty to look back on and celebrate, things to anticipate, and of course there are opportunities for improvement. What do we look forward to in 2020? We’re about to celebrate our 5th blog anniversary! It’s hard to believe that Lab Expectations is five years old.

New Year Blog Post FB_1200x630

            This year we’ll be talking a lot about immunology and cell process. We’re going to dig deeper into what expert validation means and how it is achieved. The video team is already busy producing more how-to videos to help fight through troublesome technical issues. We’ll learn more about the brilliant minds behind our antibodies. We’ll share more tips on sustainable living and community giving. And as always, we’ll share our latest resources to help you achieve experimental success.

            Around here, we talk a lot about continuous improvement. Hopefully this year will be the best yet for Lab Expectations and your lab too. Remember to share and comment on your favorite articles. And if you’ve got a great idea for a blog topic, let us know what you’d like to see!

-Cell Signaling Technology

Chris Sumner
Chris Sumner
Chris Sumner was the Editor-in-Chief of Lab Expectations. When he's not reading/writing about curing disease, he's hiking in the woods, playing guitar, or searching for the world's best lobster roll.

Recent Posts

Cell Preparation Tips for Accurate Flow Cytometry Data

Generating accurate flow cytometry data requires more than just specific and sensitive antibodies validat...
Andrea Tu, PhD Nov 6, 2024

500 Antibodies & Counting: Accelerating Discovery with CST Antibodies Validated for Simple Western Technology

Since 2022, Cell Signaling Technology (CST) and Bio-Techne have been working together to bring best-in-cl...
Chris LaBreck, PhD Oct 23, 2024

Menin-KMT2A Inhibitors: A Promising Approach to Acute Myeloid Leukemia (AML) Treatment

Accounting for about 80% of adult acute leukemias, acute myeloid leukemia (AML) is an aggressive form of ...
Homa Rahnamoun, PhD Oct 16, 2024